Brief: Humacyte Q1 Operating Expenses USD 26.578 Million
10/05/2024 12:00
May 10 (Reuters) - Humacyte Q1 basic EPS USD -0.29. * Q1 operating income USD -26.578 million vs. IBES estimate USD -25.9 million * Q1 net income USD -31.896 million vs. IBES estimate USD -25.8 million
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary